The core activity of Astellas Pharma AG is the development, manufacture and marketing of pharmaceuticals, particularly in the therapeutic areas of oncology, urology, nephrology and transplantation. The company is also engaged in research and development of new medicines and supports medical training and clinical studies.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Medicines and Therapies in Oncology, Ophthalmology, Urology, Immunology and Women's Health
Prescription medicines and transformative therapies for oncology, ophthalmology, urology, immunology and women's health; product availability may vary by region.
Research and Development
Research and development programs for new treatments focused on blindness and regeneration, genetic regulation, immuno-oncology and targeted protein degradation.
Partnering
Collaborations for discovery, development and commercialization; flexible, customer-specific partnership structures as well as licensing, academic alliances and global pharma partnerships.
Digital health solutions
Digital health solutions for chronic diseases with unmet medical need; including the Rx+ Business Accelerator and HealthX to drive digital innovation.
Manufacturing and supply
Manufacturing, packaging and global supply of pharmaceutical products, including active ingredients, formulations, clinical trial materials and commercial production under GMP standards.
Knowledge
No knowledge articles yet
Once Astellas Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.